Advertisement
Advertisement
August 27, 2017
Access Vascular Secures Financing to Support FDA Application for HydroPICC Device
August 28, 2017—Access Vascular, which develops venous access devices designed to eliminate thrombotic risk, announced $3.7 million in funding to support the submission of a 510(k) application to the US Food and Drug Administration for the company's lead product, the HydroPICC peripherally inserted central catheter, later this year. The HydroPICC device uses the company's bulk hydrophilic biomaterial platform that is designed to significantly reduce the accumulation of platelets and lower the risk of thrombosis. The funding comes from individual investors and angelMD, an investment platform and marketplace connecting innovative medical startups, physicians, investors, and industry partners.
Advertisement
Advertisement
